Augmenting Endothelial Repair in Diabetes: Role of Bone Marrow-Derived Cells

Ross, 1973, Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis, Science, 180, 1332, 10.1126/science.180.4093.1332 Asahara, 1997, Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275, 964, 10.1126/science.275.5302.964 Yoder, 2012, Human endothelial progenitor cells, Cold Spring Harb Perspect Med, 2, a006692, 10.1101/cshperspect.a006692 Jaumdally, 2010, Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus, J Intern Med, 267, 385, 10.1111/j.1365-2796.2009.02151.x Schmidt-Lucke, 2010, Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy, Atherosclerosis, 211, 249, 10.1016/j.atherosclerosis.2010.02.007 Mohler, 2009, Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterol, Cytometry Part A, 75A, 75, 10.1002/cyto.a.20691 Durik, 2012, The renin-angiotensin system, bone marrow and progenitor cells, Clin Sci (Lond), 123, 205, 10.1042/CS20110660 Endtmann, 2011, Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration, Hypertension, 58, 394, 10.1161/HYPERTENSIONAHA.110.169193 Thum, 2006, Bone marrow molecular alterations after myocardial infarction: impact on endothelial progenitor cells, Cardiovasc Res, 70, 50, 10.1016/j.cardiores.2006.01.002 Yu, 2011, ARB treatment prevents the decrease in endothelial progenitor cells and the loss of renal microvasculature in remnant kidney, Am J Nephrol, 33, 550, 10.1159/000328632 Wang, 2006, Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system, J Mol Cell Cardiol, 41, 34, 10.1016/j.yjmcc.2006.03.006 Porto, 2009, Comparison of the effects of ramipril versus telmisartan on high-sensitivity C-reactive protein and endothelial progenitor cells after acute coronary syndrome, Am J Cardiol, 103, 1500, 10.1016/j.amjcard.2009.01.370 Tipnis, 2000, A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase, J Biol Chem, 275, 33238, 10.1074/jbc.M002615200 Donoghue, 2000, A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9, Circ Res, 87, E1 Ingelfinger, 2009, Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease, Curr Opin Nephrol Hypertens, 18, 79, 10.1097/MNH.0b013e32831b70ad Sampaio, 2007, Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways, Hypertension, 49, 185, 10.1161/01.HYP.0000251865.35728.2f Benter, 2008, Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats, Am J Nephrol, 28, 25, 10.1159/000108758 Oudit, 2010, Human recombinant ACE2 reduces the progression of diabetic nephropathy, Diabetes, 59, 529, 10.2337/db09-1218 Verma, 2012, ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy, Mol Ther, 20, 28, 10.1038/mt.2011.155 Jarajapu, 2013, Activation of the ACE2/angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors, Diabetes, 62, 1258, 10.2337/db12-0808 Takahashi, 2010, Role of the SDF-1/CXCR4 system in myocardial infarction, Circ J, 74, 418, 10.1253/circj.CJ-09-1021 Askari, 2003, Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy, Lancet, 362, 697, 10.1016/S0140-6736(03)14232-8 Segers, 2007, Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction, Circulation, 116, 1683, 10.1161/CIRCULATIONAHA.107.718718 Proost, 1998, Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha, FEBS Lett, 432, 73, 10.1016/S0014-5793(98)00830-8 Zaruba, 2009, Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction, Cell Stem Cell, 4, 313, 10.1016/j.stem.2009.02.013 Shigeta, 2012, Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions, Circulation, 126, 1838, 10.1161/CIRCULATIONAHA.112.096479 Connelly, 2012, DPP-4 inhibition attenuates cardiac dysfunction and adverse remodelling following myocardial infarction in rats with experimental diabetes, Cardiovasc Ther Fadini, 2010, The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha, Diabetes Care, 33, 1607, 10.2337/dc10-0187 Fadini, 2010, Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes, Diabetes Care, 33, 1097, 10.2337/dc09-1999 Fadini, 2005, Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus, J Am Coll Cardiol, 45, 1449, 10.1016/j.jacc.2004.11.067 Egan, 2008, Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes, Diabetologia, 51, 1296, 10.1007/s00125-008-0939-6 Kusuyama, 2006, Effects of treatment for diabetes mellitus on circulating vascular progenitor cells, J Pharmacol Sci, 102, 96, 10.1254/jphs.FP0060256 Jarajapu, 2010, The promise of cell-based therapies for diabetic complications: challenges and solutions, Circ Res, 106, 854, 10.1161/CIRCRESAHA.109.213140 Hamed, 2011, Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2, Cardiovasc Res, 91, 9, 10.1093/cvr/cvq412 Hamed, 2009, Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus, Cardiovasc Diabetol, 8, 56, 10.1186/1475-2840-8-56 Segal, 2006, Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes, Diabetes, 55, 102, 10.2337/diabetes.55.01.06.db05-0803 Yuen, 2012, Angiogenic dysfunction in bone marrow-derived early outgrowth cells from diabetic animals is attenuated by SIRT1 activation, Stem Cells Transl Med, 1, 921, 10.5966/sctm.2012-0026 Asada, 1997, Recombinant insulin-like growth factor I normalizes expression of renal glucose transporters in diabetic rats, Am J Physiol, 273, F27 Limbourg, 2005, Bone marrow stem cells for myocardial infarction: effector or mediator?, Circ Res, 96, 6, 10.1161/01.RES.0000153667.26414.10 Gnecchi, 2008, Paracrine mechanisms in adult stem cell signaling and therapy, Circ Res, 103, 1204, 10.1161/CIRCRESAHA.108.176826 Yuen, 2010, Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism, PLoS One, 5, e9543, 10.1371/journal.pone.0009543 Bi, 2007, Stromal cells protect against acute tubular injury via an endocrine effect, J Am Soc Nephrol, 18, 2486, 10.1681/ASN.2007020140 Prockop, 2009, Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms, Mol Ther, 17, 939, 10.1038/mt.2009.62 Zhang, 2012, Early-outgrowth bone marrow cells attenuate renal injury and dysfunction via an antioxidant effect in a mouse model of type 2 diabetes, Diabetes, 61, 2114, 10.2337/db11-1365 Gilbert, 2013, Endothelial loss and repair in the vascular complications of diabetes: pathogenetic mechanisms and therapeutic implications, Circ J, 77, 849, 10.1253/circj.CJ-13-0236 Hare, 2009, A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction, J Am Coll Cardiol, 54, 2277, 10.1016/j.jacc.2009.06.055